RBC Capital raised the firm's price target on Healthcare Services to $24 from $22 and keeps a Sector Perform rating on the shares. The company reported a strong Q2 earnings beat and maintained guidance but the firm is cautious on the second half ramp, seeking further proof points, the analyst tells investors in a research note. RBC adds that the guide for the second half implies high single-digit top-line growth and is dependent on the timing of new client wins.
